Lifestyle cocktail aims to halt kidney disease in teens

NCT ID NCT07483697

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a combination of a controlled diet, structured exercise, and a symbiotic supplement can reduce inflammation and harmful gut toxins in young people with early chronic kidney disease (stages 1-3). Two hundred participants will receive either the multimodal intervention or standard care plus placebo for 180 days. The goal is to see if this approach can slow kidney damage and improve health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
symbiotic (probiotic and prebiotic supplement) plus diet and exercise
What this could lead to
If it works, this could point toward a simple lifestyle and supplement approach to slow early chronic kidney disease in young people.
What could go wrong
This is a small, early-stage trial with only 200 participants. The intervention is complex, so it may be hard to tell which part helps, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CKD STAGE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Instituto de Atención Integral de Enfermedades Renales del Estado de Aguascalientes

    Aguascalientes, Aguascalientes, 20180, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.